Genuine Parts Company vs Sanofi SA — how do they compare? Genuine Parts Company trades at $135.1 (market cap $18.62B), while Sanofi SA trades at $43.7 (market cap $104.30B). The key difference: Sanofi SA is far larger — about 5.6× Genuine Parts Company's market cap, and Sanofi SA pays the higher dividend (5.55%). Which is the better fit depends on your goals.
| GPC | SNY | |
|---|---|---|
Market Cap | $18.62B | $104.30B |
Sector | Consumer Cyclical | Health |
52-Week High | $149.26 | $52.34 |
52-Week Low | $92.47 | $41.33 |
Enterprise Value | $24.72B | $124.19B |
Dividend Yield | 3.15% | 5.55% |
Trailing returns across standard periods
Latest headlines on both assets
Genuine Parts sells automotive parts (about two thirds of net sales) and industrial components. The company sells vehicle parts to commercial and retail customers through roughly 9,700 stores worldwide, most of which are independently owned. Its industrial unit, primarily operating under the Motion Industries banner in the United States, supplies bearings, power transmission, industrial automation, hydraulic, and pneumatic components to maintenance, repair, and OEM clients.
Read more on GPC →Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →